Androgen Deprivation Therapy Market Size, Trends, Analysis, and Outlook By Treatment (Drug Class, Surgery), By Route of Administration (Injectable, Oral), by Country, Segment, and Companies, 2024-2032
The global Androgen Deprivation Therapy market size is poised to register 5.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Androgen Deprivation Therapy market across By Treatment (Drug Class, Surgery), By Route of Administration (Injectable, Oral)
With the increasing incidence of prostate cancer and the growing recognition of androgen receptor signaling as a key driver of disease progression, there is a rising demand for androgen deprivation therapies that suppress testosterone levels and inhibit androgen action in hormone-sensitive tumors. Market growth is driven by factors such as expanding aging population, the rising prevalence of prostate cancer risk factors such as obesity and family history, and technological advancements in hormonal agents and combination therapies. Additionally, the expanding applications of androgen deprivation therapy in urology clinics and oncology practices, as well as the growing adoption of intermittent androgen suppression regimens and adjuvant therapy approaches, contribute to market expansion. Further, the development of next-generation androgen receptor antagonists and selective androgen receptor modulators, the integration of biomarkers for treatment response and resistance prediction, and the emphasis on shared decision-making and survivorship care are expected to further accelerate market growth in the coming years.
Androgen Deprivation Therapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Androgen Deprivation Therapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Androgen Deprivation Therapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Androgen Deprivation Therapy industry.
Key market trends defining the global Androgen Deprivation Therapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Androgen Deprivation Therapy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Androgen Deprivation Therapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Androgen Deprivation Therapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Androgen Deprivation Therapy industry
Leading Androgen Deprivation Therapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Androgen Deprivation Therapy companies.
Androgen Deprivation Therapy Market Study- Strategic Analysis Review
The Androgen Deprivation Therapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Androgen Deprivation Therapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Androgen Deprivation Therapy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Androgen Deprivation Therapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Androgen Deprivation Therapy market segments. Similarly, Strong market demand is encouraging Canadian Androgen Deprivation Therapy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Androgen Deprivation Therapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Androgen Deprivation Therapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Androgen Deprivation Therapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Androgen Deprivation Therapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Androgen Deprivation Therapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Androgen Deprivation Therapy in Asia Pacific. In particular, China, India, and South East Asian Androgen Deprivation Therapy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Androgen Deprivation Therapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Androgen Deprivation Therapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Androgen Deprivation Therapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Androgen Deprivation Therapy.
Androgen Deprivation Therapy Market Company Profiles
The global Androgen Deprivation Therapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Astellas Pharma Inc, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Ferring B.V., Foresee Pharmaceuticals Co. Ltd, Johnson & Johnson, Myovant Sciences GmbH, Tolmar Pharmaceuticals Inc, Verity Pharmaceuticals Inc, Viatris Inc.
Recent Androgen Deprivation Therapy Market Developments
The global Androgen Deprivation Therapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Androgen Deprivation Therapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Treatment
Drug Class
-Luteinizing Hormone-Releasing Hormone (LHRH) agonists
-Antiandrogens
Surgery
By Route of Administration
Injectable
Oral
Geographical Segmentation:
AbbVie Inc
Astellas Pharma Inc
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Ferring B.V.
Foresee Pharmaceuticals Co. Ltd
Johnson & Johnson
Myovant Sciences GmbH
Tolmar Pharmaceuticals Inc
Verity Pharmaceuticals Inc
Viatris Inc
Formats Available: Excel, PDF, and PPT
With the increasing incidence of prostate cancer and the growing recognition of androgen receptor signaling as a key driver of disease progression, there is a rising demand for androgen deprivation therapies that suppress testosterone levels and inhibit androgen action in hormone-sensitive tumors. Market growth is driven by factors such as expanding aging population, the rising prevalence of prostate cancer risk factors such as obesity and family history, and technological advancements in hormonal agents and combination therapies. Additionally, the expanding applications of androgen deprivation therapy in urology clinics and oncology practices, as well as the growing adoption of intermittent androgen suppression regimens and adjuvant therapy approaches, contribute to market expansion. Further, the development of next-generation androgen receptor antagonists and selective androgen receptor modulators, the integration of biomarkers for treatment response and resistance prediction, and the emphasis on shared decision-making and survivorship care are expected to further accelerate market growth in the coming years.
Androgen Deprivation Therapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Androgen Deprivation Therapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Androgen Deprivation Therapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Androgen Deprivation Therapy industry.
Key market trends defining the global Androgen Deprivation Therapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Androgen Deprivation Therapy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Androgen Deprivation Therapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Androgen Deprivation Therapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Androgen Deprivation Therapy industry
Leading Androgen Deprivation Therapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Androgen Deprivation Therapy companies.
Androgen Deprivation Therapy Market Study- Strategic Analysis Review
The Androgen Deprivation Therapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Androgen Deprivation Therapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Androgen Deprivation Therapy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Androgen Deprivation Therapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Androgen Deprivation Therapy market segments. Similarly, Strong market demand is encouraging Canadian Androgen Deprivation Therapy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Androgen Deprivation Therapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Androgen Deprivation Therapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Androgen Deprivation Therapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Androgen Deprivation Therapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Androgen Deprivation Therapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Androgen Deprivation Therapy in Asia Pacific. In particular, China, India, and South East Asian Androgen Deprivation Therapy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Androgen Deprivation Therapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Androgen Deprivation Therapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Androgen Deprivation Therapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Androgen Deprivation Therapy.
Androgen Deprivation Therapy Market Company Profiles
The global Androgen Deprivation Therapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Astellas Pharma Inc, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Ferring B.V., Foresee Pharmaceuticals Co. Ltd, Johnson & Johnson, Myovant Sciences GmbH, Tolmar Pharmaceuticals Inc, Verity Pharmaceuticals Inc, Viatris Inc.
Recent Androgen Deprivation Therapy Market Developments
The global Androgen Deprivation Therapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Androgen Deprivation Therapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Treatment
Drug Class
-Luteinizing Hormone-Releasing Hormone (LHRH) agonists
-Antiandrogens
Surgery
By Route of Administration
Injectable
Oral
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Astellas Pharma Inc
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Ferring B.V.
Foresee Pharmaceuticals Co. Ltd
Johnson & Johnson
Myovant Sciences GmbH
Tolmar Pharmaceuticals Inc
Verity Pharmaceuticals Inc
Viatris Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Androgen Deprivation Therapy Market Overview and Key Findings, 2024
1.2 Androgen Deprivation Therapy Market Size and Growth Outlook, 2021- 2030
1.3 Androgen Deprivation Therapy Market Growth Opportunities to 2030
1.4 Key Androgen Deprivation Therapy Market Trends and Challenges
1.4.1 Androgen Deprivation Therapy Market Drivers and Trends
1.4.2 Androgen Deprivation Therapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Androgen Deprivation Therapy Companies
2. ANDROGEN DEPRIVATION THERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Androgen Deprivation Therapy Market Size Outlook, USD Million, 2021- 2030
2.2 Androgen Deprivation Therapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ANDROGEN DEPRIVATION THERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ANDROGEN DEPRIVATION THERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Treatment
Drug Class
-Luteinizing Hormone-Releasing Hormone (LHRH) agonists
-Antiandrogens
Surgery
By Route of Administration
Injectable
Oral
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Androgen Deprivation Therapy Market, 2025
5.2 Asia Pacific Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Androgen Deprivation Therapy Market, 2025
5.5 Europe Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Androgen Deprivation Therapy Market, 2025
5.8 North America Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.9 North America Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Androgen Deprivation Therapy Market, 2025
5.11 South America Pacific Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.12 South America Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Androgen Deprivation Therapy Market, 2025
5.14 Middle East Africa Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Androgen Deprivation Therapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Androgen Deprivation Therapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Androgen Deprivation Therapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Androgen Deprivation Therapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Androgen Deprivation Therapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Androgen Deprivation Therapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Androgen Deprivation Therapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Androgen Deprivation Therapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Androgen Deprivation Therapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Androgen Deprivation Therapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Androgen Deprivation Therapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Androgen Deprivation Therapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Androgen Deprivation Therapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Androgen Deprivation Therapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Androgen Deprivation Therapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Androgen Deprivation Therapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Androgen Deprivation Therapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Androgen Deprivation Therapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Androgen Deprivation Therapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Androgen Deprivation Therapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Androgen Deprivation Therapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Androgen Deprivation Therapy Industry Drivers and Opportunities
7. ANDROGEN DEPRIVATION THERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ANDROGEN DEPRIVATION THERAPY COMPANY PROFILES
8.1 Profiles of Leading Androgen Deprivation Therapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Astellas Pharma Inc
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Ferring B.V.
Foresee Pharmaceuticals Co. Ltd
Johnson & Johnson
Myovant Sciences GmbH
Tolmar Pharmaceuticals Inc
Verity Pharmaceuticals Inc
Viatris Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Androgen Deprivation Therapy Market Overview and Key Findings, 2024
1.2 Androgen Deprivation Therapy Market Size and Growth Outlook, 2021- 2030
1.3 Androgen Deprivation Therapy Market Growth Opportunities to 2030
1.4 Key Androgen Deprivation Therapy Market Trends and Challenges
1.4.1 Androgen Deprivation Therapy Market Drivers and Trends
1.4.2 Androgen Deprivation Therapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Androgen Deprivation Therapy Companies
2. ANDROGEN DEPRIVATION THERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Androgen Deprivation Therapy Market Size Outlook, USD Million, 2021- 2030
2.2 Androgen Deprivation Therapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ANDROGEN DEPRIVATION THERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ANDROGEN DEPRIVATION THERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Treatment
Drug Class
-Luteinizing Hormone-Releasing Hormone (LHRH) agonists
-Antiandrogens
Surgery
By Route of Administration
Injectable
Oral
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Androgen Deprivation Therapy Market, 2025
5.2 Asia Pacific Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Androgen Deprivation Therapy Market, 2025
5.5 Europe Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Androgen Deprivation Therapy Market, 2025
5.8 North America Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.9 North America Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Androgen Deprivation Therapy Market, 2025
5.11 South America Pacific Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.12 South America Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Androgen Deprivation Therapy Market, 2025
5.14 Middle East Africa Androgen Deprivation Therapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Androgen Deprivation Therapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Androgen Deprivation Therapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Androgen Deprivation Therapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Androgen Deprivation Therapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Androgen Deprivation Therapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Androgen Deprivation Therapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Androgen Deprivation Therapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Androgen Deprivation Therapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Androgen Deprivation Therapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Androgen Deprivation Therapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Androgen Deprivation Therapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Androgen Deprivation Therapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Androgen Deprivation Therapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Androgen Deprivation Therapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Androgen Deprivation Therapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Androgen Deprivation Therapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Androgen Deprivation Therapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Androgen Deprivation Therapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Androgen Deprivation Therapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Androgen Deprivation Therapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Androgen Deprivation Therapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Androgen Deprivation Therapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Androgen Deprivation Therapy Industry Drivers and Opportunities
7. ANDROGEN DEPRIVATION THERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ANDROGEN DEPRIVATION THERAPY COMPANY PROFILES
8.1 Profiles of Leading Androgen Deprivation Therapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Astellas Pharma Inc
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Ferring B.V.
Foresee Pharmaceuticals Co. Ltd
Johnson & Johnson
Myovant Sciences GmbH
Tolmar Pharmaceuticals Inc
Verity Pharmaceuticals Inc
Viatris Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
